Zimilevich Min Kyung MD - 32501 Pensacola, FL

Business Name: Zimilevich Min Kyung MD
Categorized In: Doctors
Address: 1000 West Moreno St, Pensacola, FL 32501
Phone Number: (850) 434-4011
Contact Person: Min Kyung Zimilevich
Website Address: ebaptisthealthcare.org
NAICS Code: 6211110
SIC Code: 8011
Business Type: B2C (Business to Consumer)
Employee #: 1 to 4
Location Type: Single Location
Annual Revenue ($): $500.000 to $999.999
Share This Business:
Similar Businesses: Turner Susan E MD - Pensacola, FL 32501
Amos Henry MD - Pensacola, FL 32501
Herrera German MD - Pensacola, FL 32501
Elaine Sharp Md - Pensacola, FL 32501
Langhorne III W Henry MD - Pensacola, FL 32501
Boden John M MD - Pensacola, FL 32501
Gulf Coast Radiation Oncology - Pensacola, FL 32501
Dr Kazys J Jankauskas Md - Pensacola, FL 32501
Escambia County Health Facilit - Pensacola, FL 32501
Leker James MD - Pensacola, FL 32501
Shao Gincauskas Bentz & Nalley Md's Pa - Pensacola, FL 32501
Kugelman Cancer Center - Pensacola, FL 32501
Bernard Bradley C MD - Pensacola, FL 32501
Al-Sheikh Thabet MD - Pensacola, FL 32501
Thiele Mark R MD - Pensacola, FL 32501
Samson Rogelio D MD - Pensacola, FL 32501
Riley Scott I MD - Pensacola, FL 32501
Hof Scott M MD - Pensacola, FL 32501
Smith Robert M MD - Pensacola, FL 32501
Dolister Michael MD - Pensacola, FL 32501

Zimilevich Min Kyung MD provides professional Doctors from its single location at the coordinates 30.42873,-87.23215.

The company offers B2C variables under the SIC code 8011 and NAICS code 6211110, while making an annual revenue of $500.000 to $999.999 and hiring a total of 1 to 4 employees.

Founded in 0, the company can now be visited at 1000 West Moreno St, Pensacola, Florida 32501 or contacted through representative Min Kyung Zimilevich at (850) 434-4011.

For frequently asked questions and further inquiries about professional Doctors, get to know more about Zimilevich Min Kyung MD through its company website at ebaptisthealthcare.org. Engage with this business on its social media platforms through on Twitter and on Facebook.